Aktis Oncology Revenue

In the year 2025, Aktis Oncology had annual revenue of $6.50M with 336.92% growth. Aktis Oncology had revenue of $1.87M in the quarter ending December 31, 2025.

Revenue (ttm)

$6.50M

Revenue Growth

+336.92%

P/S Ratio

180.88

Revenue / Employee

$82,241

Employees

Market Cap

1.18B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.50M	5.01M	336.92%
Dec 31, 2024	1.49M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

AKTS News

10 days ago - Aktis Oncology Appoints Industry Research and Development Veteran Glenn Gormley, MD, PhD to its Board of Directors - GlobeNewsWire
27 days ago - Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results - GlobeNewsWire
6 weeks ago - Aktis Oncology Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
7 weeks ago - Aktis Oncology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
2 months ago - Aktis Oncology to Present at Upcoming March Investor Conferences - GlobeNewsWire
2 months ago - Aktis Oncology Receives U.S. FDA Fast Track Designation for AKY-1189, a Nectin-4 Miniprotein Radioconjugate - GlobeNewsWire
3 months ago - Aktis Oncology Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
3 months ago - Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets - Business Wire

More News